GovChime
Notice ID: b4f6b3c149844542a1e1b5490e0a9fbdSpecial Notice

Notice of Intent to Sole-Source to BioFire Defense LLC for laboratory testing supplies and kits

Archived on December 30, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:00 AM UTC−05:00
Posted
December 5, 2024
Notice type
Special Notice
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of State

Notice details

Office
ACQUISITIONS - AQM MOMENTUM
Place of performance
Arlington, VA, 22209
Last updated
Jan 23, 2026

Identifiers

Solicitation number
19AQMM25Q0012
Notice ID
b4f6b3c149844542a1e1b5490e0a9fbd

Description

The Department of State Office of Global Acquisitions, Acquisitions Management (A/GA/AM), on behalf of the Office of Global Operations, Logistics Operations and Supply Chain Management (A/GO/OPS/SCM) intends to award a Firm-Fixed Price Blanket Purchase Agreement {BPA) for Biomerieux (BioFire Defense) laboratory testing supplies under a Federal Supply Schedule contract to BioFire Defense LLC, 79 West 4500 South Suite 14, Salt Lake City, Utah 84107. This acquisition is conducted under the authority of the Multiple-Award Schedule Program (41 U.S.C. 152(3) and 40 U.S.C. 501), as implemented in FAR 8.405.6 by the following: Federal Acquisition Regulation FAR 8.405-G(a)(l)(i)(B) - Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. The primary North American Industry Classification System (NAICS) code is 325413- In-Vitro Diagnostic Substance Manufacturing. A signed and approved Limited Sources Justification is provided with this notice. No Request for Quote (RFQ) will be available for competitive quotes. This notice is not a request for competitive quotations; however, the government will consider responses to this notice within 10 days of this posting. Interested parties may express their interest and provide a capabilities statement N.L.T. Sunday, 15 December 2024 at 11:00 AM EST.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

Showing 1 of 1 items

Document
Source
Agency
Posted Date
File Size
Actions
Special NoticeSTATE, DEPARTMENT OFDec 5, 2024-

Lifecycle

Solicitation:19AQMM25Q0012
  1. Special NoticeCurrentDec 5, 2024

    Notice of Intent to Sole-Source to BioFire Defense LLC for laboratory testing supplies and kits

    Notice b4f6b3c149844542a1e1b5490e0a9fbd on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Attached is the award for Trazodone.
-AwardedOpen
Combined synopsis/solicitation for Immunoassay Reagents, Supplies and Consumables to be used for patient testing on an existing Architect i1000 analyzer located at the Pathology and Laboratory Medicine Services in Southern Arizona VA Medical Center (VA Tucson).
-Combined Synopsis11/13/2026
Boise, Idaho VAMC Transfusion Services requires red blood cell reagents that meet strict quality control and compliance standards for patient testing. These reagents are essential for safely matching donated blood products to recipients who need them for life-saving treatments—a process carried out exclusively in the Transfusion Services Department. The vendor is responsible for supplying quality control check cells as well as antibody identification panel cells to fulfill these requirements and support effective patient care. 5-year agreement. Base Year Period of Performance: 12/01/2026-11/30/2027. Four option years to follow based upon the Government's needs and discretion. Transfusion Medicine supports all major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. Without a dedicated Transfusion Medicine Department, these units cannot operate effectively. Each VAMC needs its own department, as services are site-specific across the VISN. The vendor must keep track of the lot numbers and expiration dates for each reagent provided to the Boise VAMC Blood Bank. Since these reagents are made from cellular material, they expire quickly. The vendor should send the new lot number shortly before the old one expires to ensure the Blood Bank always has the necessary reagents for matching blood products. The vendor shall supply the Transfusion Service with red blood cells reagents that meet the current standards and/or regulations of the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB) to ensure patient safety.
-Solicitation11/18/2026
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.
-Combined Synopsis11/18/2026
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels.
-Market Research11/27/2026

Additional Details

Solicitation Number

19AQMM25Q0012

Archive Date

Dec 30, 2024

Office Address

WASHINGTON, DC, 20520